What's in Daré Bioscience, Inc.'s pipeline?

Daré Bioscience, Inc. has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Daré Bioscience, Inc.'s portfolio?

Top competitors by shared drug class: Actavis Inc., Amneal Pharmaceuticals, LLC, Amzell, Assaf-Harofeh Medical Center, Azienda USL Reggio Emilia - IRCCS.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dar-bioscience-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Daré Bioscience, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Daré Bioscience, Inc. pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Diclofenac 1%	Diclofenac 1%	marketed	Nonsteroidal anti-inflammatory drug (NSAID)	COX-1 and COX-2	Pain Management / Rheumatology

Therapeutic area mix

Pain Management / Rheumatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Actavis Inc. · 1 shared drug class
Amneal Pharmaceuticals, LLC · 1 shared drug class
Amzell · 1 shared drug class
Assaf-Harofeh Medical Center · 1 shared drug class
Azienda USL Reggio Emilia - IRCCS · 1 shared drug class
Bausch & Lomb Incorporated · 1 shared drug class
Bayer · 1 shared drug class
Abbott · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Daré Bioscience, Inc.:

Cite this brief

Drug Landscape (2026). Daré Bioscience, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dar-bioscience-inc. Accessed 2026-06-10.